Literature DB >> 24776733

Hyperinsulinaemic androgen excess in adolescent girls.

Lourdes Ibáñez1, Ken K Ong2, Abel López-Bermejo3, David B Dunger4, Francis de Zegher5.   

Abstract

Hyperinsulinaemic androgen excess is the most common cause of hirsutism, acne and menstrual irregularity in adolescent girls. Here, we propose that the disorder frequently originates from an absolute or relative excess of lipids in adipose tissue, and from associated changes in insulin sensitivity, gonadotropin secretion and ovarian androgen release. Girls from populations with genotypes attuned to nutritionally harsh conditions seem to be particularly vulnerable to the development of hyperinsulinaemic androgen excess in today's obesogenic environment. We propose that hirsutism, hyperandrogenaemia and menstrual irregularity (≥2 years after menarche) is used as a diagnostic triad for the disorder. No pharmacological therapy has been approved for girls with androgen excess; however, lifestyle intervention is essential to reduce adiposity. In girls without obesity who are not sexually active, insulin sensitization has more broadly normalizing effects than estradiol-progestogen combinations. The early recognition of girls at risk of developing hyperinsulinaemic androgen excess might enable prevention in childhood.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24776733     DOI: 10.1038/nrendo.2014.58

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  159 in total

1.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

Authors:  Zi-Jiang Chen; Han Zhao; Lin He; Yuhua Shi; Yingying Qin; Yongyong Shi; Zhiqiang Li; Li You; Junli Zhao; Jiayin Liu; Xiaoyan Liang; Xiaoming Zhao; Junzhao Zhao; Yingpu Sun; Bo Zhang; Hong Jiang; Dongni Zhao; Yuehong Bian; Xuan Gao; Ling Geng; Yiran Li; Dongyi Zhu; Xiuqin Sun; Jin-E Xu; Cuifang Hao; Chun-E Ren; Yajie Zhang; Shiling Chen; Wei Zhang; Aijun Yang; Junhao Yan; Yuan Li; Jinlong Ma; Yueran Zhao
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

Review 2.  Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.

Authors:  Lourdes Ibáñez; Francis de Zegher
Journal:  Hum Reprod Update       Date:  2006-01-11       Impact factor: 15.610

3.  Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.

Authors:  L Ibáñez; N Potau; M V Marcos; F De Zegher
Journal:  Clin Endocrinol (Oxf)       Date:  2000-10       Impact factor: 3.478

4.  Estrogen receptor-mediated repression of human hepatic lipase gene transcription.

Authors:  Daniel R Jones; Robert J Schmidt; Richard T Pickard; Patricia S Foxworthy; Patrick I Eacho
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

5.  Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis.

Authors:  Shiyao He; Yu-hong Tang; Guobin Zhao; Xiaolong Yang; Dehou Wang; Ye Zhang
Journal:  Tumour Biol       Date:  2013-10-04

Review 6.  Diagnosis and treatment of polycystic ovarian syndrome in adolescents.

Authors:  Katrina F Nicandri; Kathleen Hoeger
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

Review 7.  The Polycystic Ovary Syndrome and recent human evolution.

Authors:  Stephen Corbett; Laure Morin-Papunen
Journal:  Mol Cell Endocrinol       Date:  2013-01-23       Impact factor: 4.102

8.  Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.

Authors:  Jean-Baptiste Armengaud; Marie-Laure Charkaluk; Christine Trivin; Véronique Tardy; Gérard Bréart; Raja Brauner; Martin Chalumeau
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

9.  Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls.

Authors:  Ken K Ong; Neus Potau; Clive J Petry; Richard Jones; Andrew R Ness; John W Honour; Francis de Zegher; Lourdes Ibáñez; David B Dunger
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Ilaria Belluomo; Andrea Repaci; Valentina Diana Di Lallo; Guido Di Dalmazi; Marco Mezzullo; Olga Prontera; Gaia Cuomo; Laura Zanotti; Alexandro Paccapelo; Antonio Maria Morselli-Labate; Uberto Pagotto; Renato Pasquali
Journal:  J Clin Endocrinol Metab       Date:  2013-06-18       Impact factor: 5.958

View more
  15 in total

1.  Polycystic ovary syndrome and (pre)osteoarthritis: assessing the link between hyperandrogenism in young women and cartilage oligomeric matrix protein as a marker of cartilage breakdown.

Authors:  Plamena Kabakchieva; Tsvetoslav Georgiev; Antoaneta Gateva; Julieta Hristova; Zdravko Kamenov
Journal:  Clin Rheumatol       Date:  2021-05-04       Impact factor: 2.980

2.  Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome.

Authors:  Laura C Torchen; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

3.  The effect of metformin treatment on leukocyte telomere length in patients with polycystic ovary syndrome: a prospective case-control study.

Authors:  Özlem Kayacık Günday; Müjgan Özdemir Erdoğan; Ayşen Pehlivan; Mehmet Yılmazer
Journal:  J Assist Reprod Genet       Date:  2022-07-21       Impact factor: 3.357

Review 4.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 5.  Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like Traits.

Authors:  David H Abbott; Jon E Levine; Daniel A Dumesic
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  Free androgen index and Irisin in polycystic ovary syndrome.

Authors:  H Li; X Xu; X Wang; X Liao; L Li; G Yang; L Gao
Journal:  J Endocrinol Invest       Date:  2015-11-19       Impact factor: 4.256

7.  Metabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.

Authors:  Sara Samino; Maria Vinaixa; Marta Díaz; Antoni Beltran; Miguel A Rodríguez; Roger Mallol; Mercedes Heras; Anna Cabre; Lorena Garcia; Nuria Canela; Francis de Zegher; Xavier Correig; Lourdes Ibáñez; Oscar Yanes
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

8.  The impact of obesity on hyperandrogenemia in Korean girls.

Authors:  Min Jae Kang; Seung Yang; Il Tae Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-12-31

Review 9.  Curtailing PCOS.

Authors:  Selma Feldman Witchel; Helena J Teede; Alexia S Peña
Journal:  Pediatr Res       Date:  2019-10-18       Impact factor: 3.756

10.  Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Yerui Lai; Jinhua Chen; Ling Li; Jingxia Yin; Junying He; Mengliu Yang; Yanjun Jia; Dongfang Liu; Hua Liu; Yong Liao; Gangyi Yang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.